Pavone-Macaluso M - Search Results

1

Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis.

Lopez-Beltran A, Bassi P, Pavone-Macaluso M, Montironi R. Lopez-Beltran A, et al. Eur Urol. 2004 Mar;45(3):257-66. doi: 10.1016/j.eururo.2003.09.018. Eur Urol. 2004. PMID: 15036668 Review.

2

Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis. A joint proposal of the European Society of Uropathology and the Uropathology Working Group.

Lopez-Beltran A, Bassi PF, Pavone-Macaluso M, Montironi R; European Society of Uropathology; Uropathology Working Group. Lopez-Beltran A, et al. Virchows Arch. 2004 Aug;445(2):103-10. doi: 10.1007/s00428-004-1039-8. Epub 2004 Jun 8. Virchows Arch. 2004. PMID: 15185074 Review.

3

The pathology of bladder cancer: An update on selected issues.

Pavone-Macaluso M, Lopez-Beltran A, Aragona F, Bassi P, Fitzpatrick JM. Pavone-Macaluso M, et al. BJU Int. 2006 Dec;98(6):1161-5. doi: 10.1111/j.1464-410X.2006.06445.x. Epub 2006 Jul 28. BJU Int. 2006. PMID: 16879435 Review.

4

Study of cellular DNA content by flow cytometry in primary bladder carcinomas. Significance of monoclonal and multiclonal varieties of DNA aneuploidy.

Campanella R, Russo A, Plaja S, Bazan V, Pavone C, Corselli G, Pavone-Macaluso M. Campanella R, et al. Eur Urol. 1992;21(1):58-63. doi: 10.1159/000474802. Eur Urol. 1992. PMID: 1606985

5

TUR and adjuvant intravesical chemotherapy in T1G3 bladder tumors: recurrence, progression and survival in 137 selected patients followed up to 20 years.

Serretta V, Pavone C, Ingargiola GB, Daricello G, Allegro R, Pavone-Macaluso M. Serretta V, et al. Eur Urol. 2004 Jun;45(6):730-5; discussion 735-6. doi: 10.1016/j.eururo.2003.12.002. Eur Urol. 2004. PMID: 15149744

6

The fate of patients with locally advanced bladder cancer treated conservatively with neoadjuvant chemotherapy, extensive transurethral resection and radiotherapy: 10-year experience.

Serretta V, Lo Greco G, Pavone C, Pavone-Macaluso M. Serretta V, et al. J Urol. 1998 Apr;159(4):1187-91. J Urol. 1998. PMID: 9507829 Clinical Trial.

7

Vaginal metastasis from renal cell carcinoma: the role of electron microscopy.

Serretta V, Pavone C, Messina G, Caramia G, Pavone-Macaluso M. Serretta V, et al. Eur Urol. 1989;16(1):78-9. doi: 10.1159/000471537. Eur Urol. 1989. PMID: 2714325

8

Gemcitabine in intravesical treatment of Ta-T1 transitional cell carcinoma of bladder: Phase I-II study on marker lesions.

Serretta V, Galuffo A, Pavone C, Allegro R, Pavone-MacAluso M. Serretta V, et al. Among authors: pavone macaluso m. Urology. 2005 Jan;65(1):65-9. doi: 10.1016/j.urology.2004.08.027. Urology. 2005. PMID: 15667865 Clinical Trial.

9

Results of conservative treatment (transurethral resection plus adjuvant intravesical chemotherapy) in patients with primary T1, G3 transitional cell carcinoma of the bladder.

Serretta V, Piazza S, Pavone C, Piazza B, Pavone-Macaluso M. Serretta V, et al. Urology. 1996 May;47(5):647-51. doi: 10.1016/s0090-4295(96)00007-6. Urology. 1996. PMID: 8650860 Clinical Trial.

10

Adjuvant chemotherapy for superficial transitional cell bladder carcinoma: long-term results of a European Organization for Research and Treatment of Cancer randomized trial comparing doxorubicin, ethoglucid and transurethral resection alone.

Kurth K, Tunn U, Ay R, Schröder FH, Pavone-Macaluso M, Debruyne F, ten Kate F, de Pauw M, Sylvester R. Kurth K, et al. J Urol. 1997 Aug;158(2):378-84. doi: 10.1016/s0022-5347(01)64484-7. J Urol. 1997. PMID: 9224307 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

174 results

Search Page